**Selected for Doody’s Core Titles® 2024 in Endocrinology/Metabolic Disease**
Updated with new and expanded chapters, Endocrine Disruption and Human Health, Second Edition provides an introduction to what endocrine disruptors are, the issues surrounding them, the source of these chemicals in the ecosystem and the mechanisms of action and assay systems. Contributions by specialists are included to discuss the varying effects of endocrine disruption on human health, and procedures for risk assessment of endocrine disruptors, and current approaches to their regulation are also covered.
With new material on topics such as low-term, low dose mixtures, windows of susceptibility, epigenetics, EDCs effect on the gut microbiome, EDCs in from polluted air and oral exposures, green chemistry, and nanotechnology, the new edition of Endocrine Disruption and Human Health is a valuable and informative text for academic and clinical researchers and other health professionals approaching endocrine disruption and its effects on human health for the first time, graduate students, and advanced undergraduate students.
- Provides readers with access to a range of information from the basic mechanisms and assays through to cutting-edge research investigating concerns for human health
- Presents a comprehensive, translational look at all aspects of endocrine disruption and its effects on human health
- Offers guidance on the risk assessment of endocrine disruptors and current relevant regulatory considerations
- Newly added content on topics like low-term, low dose mixtures, windows of susceptibility to EDCs, EDCs effect on the gut microbiome, green chemistry, and nanotechnology
Professor Philippa Darbre is Professor Emeritus in Oncology in the School of Biological Sciences at the University of Reading in the UK. She is an academic scientist who has been carrying out research into estrogen action in breast cancer for over 40 years and has been investigating the role of estrogen-mimicking chemicals since before the term “endocrine disruption” came into being in the early 1990s. She trained as a biochemist and holds the degrees of BScHons from the University of Birmingham, UK (1973) and PhD from the University of Cambridge, UK (1977). Her postdoctoral research began at the Molecular Medicine Institute at the University of Oxford where she held the first Nuffield Medical Research Fellowship of the University of Oxford and a Junior Research Fellowship at St Hugh’s College. In 1981, she moved to the Imperial Cancer Research Fund laboratories in central London (now Cancer Research UK) where she became Head of the Cellular Endocrinology Laboratory. In 1991, she moved to the University of Reading and retired to Emeritus status in 2017. From retirement, she continues research into the role of endocrine disrupting chemicals in breast cancer together with some teaching of undergraduates in endocrinology and cancer. She continues to serve on the editorial board of the Journal of Applied Toxicology, is patron of the charity “Canceractive” and is a member of the science panel of the charity, BreastCancer UK. She has written two books on molecular biology methods, has guest-edited a previous journal volume on endocrine disrupters, has published 150 peer-reviewed research papers, and served as founding editor of the first edition of the book, Endocrine Disruption and Human Health.
